Fig 3 - uploaded by Frode Miltzow Skjeldal
Content may be subject to copyright.
FT-IR spectrum. ( a ) sebacic acid ( b ) polysebacic anhydride. 

FT-IR spectrum. ( a ) sebacic acid ( b ) polysebacic anhydride. 

Source publication
Article
Full-text available
Purpose The aim of this study was to design stimuli-responsive nanocarriers for anti-cancer drug delivery. For this purpose, doxorubicin (DOX)-loaded, polysebacic anhydride (PSA) based nanocapsules (NC) were combined with pH-sensitive poly (L-histidine) (PLH). Method PSA nano-carriers were first loaded with DOX and were coated with poly L-histid...

Context in source publication

Context 1
... plotted versus time. All experiments were carried out in triplicates. The anti-tumor activity of the prepared pH responsive NCs was examined on the MDA-MB-231 breast cancer cells purchased from the American Type Culture Collection (ATCC). Cell viability assay included blank wells containing medium only, untreated control cells and cells treated with the empty NCs, free DOX and DOX-loaded nanoparticles. Briefly, the breast cancer cells were seeded in 96-well plates, incubated for 24 h and treated by 100 μ L sterile PBS (blank groups) as well as PBS solution containing unloaded nanocapsules (blank NCs), free DOX (0.6 μ g/mL) and DOX containing nanocapsules (PEG-PLH-PSA-DOX-NCs) (0.6 μ g/mL and 1.2 μ g/mL). After 3 days of incubation at 37°C and 5% CO 2 , cell viability was estimated by adding 10 μ L of WST Kit-8 that was added to each well and incubated for 2 h. The absorbance values of the wells were obtained by UV spectroscopy (Wallac Victor plate reader, Turku, Finland) at 450 nm. To visualize the intracellular uptake of DOX containing nanocapsules by the cells, confocal laser scanning microscopy was employed. To accomplish this, MDA-MB-231 cells (15,000 cells per well) were seeded in 8-well glass slide (Lab- Tek II, NY, USA), incubated for 24 h and then treated with sterile PBS (0.01 M), PBS containing free DOX (0.6 μ g/mL) and nanocapsules containing the same amount of DOX (PEG-PLH-PSA-DOX-NCs). After 3-days incubation, the medium was removed and the cells were rinsed twice with sterile PBS (0.067 M, pH 7.4). Fixing was accomplished by adding 400 μ L of cold paraformaldehyde (PFA, 4%) and by incubating for 15 min at room temperature. Excess paraformaldehyde was removed by rinsing with sterile PBS (0.067 M, pH 7.4). After fixing, the cell nucleus was labeled with DAPI (4 ′ ,6-diamidino-2-phenylindole) by adding one droplet of pro- long gold antifade reagent containing DAPI (Invitrogen, Oregon-USA) to each well. Fixed cells were covered by cover slips, kept at 2 – 8°C for 24 h and they were inspected by a Zeiss LSM 710 confocal microscope, equipped with Plan- Apochromatic 63×1.4 NA oil immersion objective (Zeiss- Germany). The image processing and visualization were performed by using the ZEN 2011 software (Carl Zeiss, Germany). Cell uptake of nanocapsules by cancerous cells was also examined by fluorescence microscopy. In this experiment, MDA-MB-231 breast cancer cells were seeded in 8-well glass slide (15,000 cells per well) and treated with sterile PBS as a control group, free DOX and Coumarin-labeled PEG-PLH- PSA-DOX-NCs. Treated cells were incubated for 1 day and fixed by PFA (4%) as described above. The influence of PEGylation of nanocapsules on macrophage uptake was analyzed on human acute monocytic leukemia cells (THP-1) that were obtained as a kind gift from Dr. Lina Prasmickaite and grown in RPMI 1640 cell culture medium (Lonza, Verviers, Belgium) containing 10% fetal bovine serum, 1% penicillin-streptomycin and 2 mM Glutamine. THP-1 cells were seeded (15,000 cells per well) in 8-well glass slide and induced to differentiate into macrophages by adding 200 μ L culture medium containing 10 μ M TPA (12-O- tetradecanoyl-phorbol-13-acetate) and incubated at 37°C in the presence of 5% CO 2 . After 48 h, the macrophages were treated by replacing TPA containing medium with sterile PBS, PEGylated NCs (PEG-PLH-PSA-DOX-NCs) and non-PEGylated NCs (PLH-PSA-DOX-NCs) with DOX concentration of 0.6 μ g/mL. Treated macrophages were incubated for 6 h and fixed by paraformaldehyde (4%) as described above for the microscopy study. From three represen- tative experiments, we analysed 10 cells with the uptake of non-PEGylated beads and 17 cells with the uptake of PEGylated beads. The level of total Doxorubicin fluorescence in the individual cells was measured as a function of relative difference in integrated intensity to the nucleus (DAPI) label- ing of the cells. No saturated pixels were present and no background subtraction was performed. The individual nucleus was manually masked by freehand selection to avoid any discrepancies due to size, fluorescence intensity or shape. The total fluorescence intensity of the DOX loaded into PEGylated and non-PEGylated particles was measured with ImageJ [17]. Data is presented as mean and standard deviation, and the statistical significance was tested with a two- tailed Mann – Whitney test. The values having p ≤ 0.0014 was considered significant (GraphPad, Prism). The H-NMR spectra of both sebacic acid and polysebacic anhydride are compared in Fig. 2. It was found that the peak related to the OH groups located at 10.49 ppm, representing the monomer structure [3, 14] has disappeared in the spectrum of the synthesized polysebacic anhydride. This phenomenon is related to the conversion of carboxylic acid groups to anhydride. In addition, FTIR analysis confirmed the synthesis of the polysebacic anhydride. The FTIR spectra of both sebacic acid and polysebacic anhydride are shown in Fig. 3. The spectrum of sebacic acid showed characteristic absorption bands at 1,697, 1,300 and 930 cm − 1 , representing carboxylic acid groups (Fig. 3a). The broad band presented at 3,335 – 2,500 cm − 1 was ascribed to the strong hydrogen bond- ing of the -OH groups of the free acid. In the case of the spectrum for the polymer (Fig. 3b), these bands disappeared and the polysebacic anhydride characteristic absorption band was observed at 1,816 – 1,740 cm − 1 . A sharp peak in the range of 1,090 – 1,030 illustrates stretching of the anhydride groups ( − CO-O-CO-) [12]. Peaks observed in the domain of 2,920 and 2,870 cm − 1 are related to stretching of C-H bonds in CH 2 groups. Results obtained from GPC demonstrated that the molecular weight of the prepared PSA is about 2,500 Da with a polydispersity index (PDI) of 1.30. Although the main strategy of this study was to target DOX via pH-responsive nanocapsules, the enhanced permeability and retention (EPR) effects of nano-size particles were also expected to contribute to the entrapping of nanocapsules to the solid tumor [18]. To exploit the EPR effect in tumor targeting, relatively small nanocapsules are required [3]. The results from dynamic light scattering (DLS) for DOX loaded NCs, before coating with PLH and PEG (PSA-DOX-NCs), are shown in Fig. 4. The size distribution of particles was rather broad, but most of the particles were located in the range of 150 – 350 nm. SEM micrographs exhibited a fine spherical morphology for PSA-DOX-NCs (Fig. 5). The drug delivery systems are usually defined as a delivery technique to carry at least two-fold dosage of pharmaceutical agents compared to conventional drug administration [19]. Hence, encapsulation efficiency and loading capacity of NPs are important for sustained delivery. The challenge for polymer-based drug delivery systems is to obtain a sufficiently high drug loading capacity. The water-soluble DOX exhibits weak amphipathic properties (pK a 8.3) and it is generally difficult to encapsulate the drug from an aqueous medium. There are also various challenges related to improving the DOX loading efficiency by preventing its migration from the organic to the aqueous phase, which is the main cause of the high amount of non-loaded drug in the supernatant. In some studies, cooperation of DOX with anionic polymers [20, 21] and interaction of an anionic surfactant [22] was used to develop DOX encapsulation efficiency up to 42.5 and 49.3%, respectively. In our study, encapsulation efficiency and loading capacity of DOX in polysebacic anhydride based nanocapsules were estimated to be 48 and 5.3%, respectively. These values are close to the reported [20 – 22] values for encapsulation of DOX in nanocapsules. In the literature there are plenty of studies aimed to improve encapsulation efficiency of highly hydrophilic DOX. It was shown that encapsulation efficiency of DOX can be significantly improved by either using negatively charged polymers [23] or co-encapsulation of DOX with other gradients such as ammonium sulfate [24]. Consequently, NCs fabricated in this study via the double emulsion method exhibited acceptable drug encapsulation for DOX delivery, without any modification of the polymer to entrap more DOX. Poly (L-histidine) (PLH) is a biodegradable polyamino acid. The polymer backbone has many imidazole functional groups with pKa around 6.0 and PLH exhibits buffering properties in the physiological pH range. Imidazole groups can be protonated at pH below 5.8, and as a consequence PLH can be dissolved in dilute acids [25]. This feature has been used to design different PLH based complexes as pH-sensitive delivery systems. For instance, PLH has been applied either as an outer shell or in cooperation with alginate to prepare microcapsules used for protein delivery [26]. In these studies, PLH was defined as a promising compound for protein delivery. In order to test the pH-response of poly (L-histidine), DOX loaded NCs (PSA-DOX-NCs) were coated with PLH by adsorbing PLH molecules on the NCs surfaces through elec- trostatic interactions. For this purpose, zeta potential of both DOX loaded NCs and PLH were measured in dilute acid medium with the intension to create the same condition needed for coating. The results showed zeta potential values of +29.4 and − 35 mV for PLH and PSA-DOX-NCs, respectively. The results favor the conjecture that positively charged PLH can be adsorbed onto negatively charged NCs. To provide more evidence for this hypothesis, PLH-coated NCs (PLH- PSA-DOX-NCs) were characterized by FTIR to establish whether the absorbance peaks coming from PLH functional groups can be detected in the FTIR spectrum of the NCs. Figure 6 shows FTIR spectra for DOX loaded nanocapsules (PSA-DOX-NCs) (Fig. 6a), DOX loaded nanocapsules coated with PLH (PLH-PSA-DOX-NCs) (Fig. 6b), and pure PLH used as blank (Fig. 6c) to compare the success of the coating. A comparison of FTIR-spectra reveals that the spectrum ...

Citations

... FT-IR results for pure drugs and loaded NiFe@C-PF127 are shown in Fig. S3. The result obtained for pure drugs revealed high similarity with reported literature [72,73]. Comparing the functionalized nanoparticles spectra with the result obtained for both drug loaded nanoparticles reveals different results, which are related to the presence of the drug on the nanoparticles. ...
Article
Full-text available
The nanoparticles designed for application in cancer treatment should have biocompatibility, colloidal stability and triggered release at tumor sites. Magnetic nanoparticles arise as an interesting option to be used as drug nanocarriers, considering the possibility of driving nanoparticles to the correct delivery site and exploring different triggers to achieve such accomplishment. In this study, nickel ferrite nanoparticles are explored as a magnetic core for drug delivery systems, using doxorubicin and omeprazole as model drugs. The developed nickel ferrite presents a strong superparamagnetic behavior and high purity, as demonstrated by magnetometry and TGA results. The carbon-coating procedure and functionalization allowed the nanoparticle to achieve the desired characteristics for biomedical applications (i.e. stability in water, biocompatibility, and size). According to TEM results, the final carbon-coated magnetic nanoparticles have an average size of 25.09 ± 0.58 nm and multi-core shell architecture, which is suitable for biomedical applications as drug nanocarriers. In addition, DLS demonstrated that functionalized nanoparticles are monodisperse, with a hydrodynamic diameter of 167 ± 59 nm, which fits the recommended range (100-200 nm) to benefit from enhanced permeability and retention effect. Drug loading tests with doxorubicin and omeprazole revealed the versatility of the designed nanoparticles, able to load 97% of doxorubicin and 51% of omeprazole. The pH-triggered release was also confirmed for both pharmacological compounds, showing a higher cumulative drug under acidic conditions (simulating a tumor microenvironment). Finally, the kinetic analysis applied to the study of the release mechanism of both medicines showed that non-linear models fit with higher accuracy the experimental data.
... In the other study, amphiphilic four-arm star-polymers-poly-(e-caprolactone)-b-poly-(2-(diethylamino) ethylmethacrylate) was used. These studies showed a pH-dependent drug release profile with the promising intracellular release of the cargo [51,52]. ...
Article
Full-text available
Review Controlled and Targeted Drug Delivery Using Smart Nanovectors Abou Bakr M. Salama 1,2, Yasmin Y. Salem 1,2, and Tamer M. A. Mohamed 1,3,4,5,6, * 1 Institute of Molecular Cardiology, Department of Medicine, University of Louisville, KY 40208, U.S.A. 2 Faculty of Medicine, Zagazig University, Zagazig 44519, Egypt. 3 Envirome Institute, Centre for Cardiometabolic Sciences, Department of Medicine, University of Louisville, KY 40208, U.S.A. 4 Department of Bioengineering, Speed School of Engineering, University of Louisville, KY 40208, U.S.A. 5 Department of Pharmacology and Toxicology, University of Louisville, KY 40208, U.S.A. 6 Institute of Cardiovascular Sciences, University of Manchester M13 9PL, U.K. * Correspondence: tamer.mohamed@louisville.edu Received: 28 January 2023 Accepted: 23 February 2023 Published: 20 March 2023 Abstract: The conventional drug delivery systems have several limitations, such as the high frequency of administration, several off-target effects, and the need for tissue specificity. Recently, smart drug shuttles have emerged, and the nano applications provided a new opportunity for advancing the drug delivery system to become tissue targeted and decrease the frequency of administration. The recent development of nanovectors as drug carriers has gone through several steps of evolution that ended with the development of logic-embedded nanovectors. Here, we summarize the different types of nanovectors and their applications in various clinical situations, and finally, we spot the light on the future of this area of research.
... Several groups present in polymers, like tertiary amine, sulfonic, carboxyl, phosphate, and pyridine groups, get ionized in response to pH change and bring about changes, like configuration, degradability, chain conformation swelling, shrinking, solubility, selfassembly, and surface activity [104]. pH responsiveness of materials has been exploited in several biomedical applications, such as gene delivery, glucose sensors, and drug delivery [105]. Cancers or inflammation causes pH change in the tissue microenvironment. ...
Article
Background Four-dimensional (4D) printing is an advancement of three-dimensional (3D) printing technology, which allows a static 3D-printed structure to transform its shape with time, via self-folding/unfolding, in the presence of external stimuli, such as temperature, light, pH, water, mechanical stress, and magnetic field. According to the reports, this technology has tremendous potential in the area of biomedical engineering.Objective To review the recent research and application breakthroughs of 4D printing in various biomedical fields, such as tissue engineering, wound healing, drug delivery, soft robotics, and other medical devices.Materials and MethodsA thorough literature search has been performed regarding the 4D printing technology and its application in biomedical engineering using the “Web of Science” browser.ResultsAfter reviewing all the available literature related to the biomedical application of 4D printing, it can be summarized that 4D printing technology has remarkably diverse biomedical application potential.Conclusion4D printing technology revolutionizes research in the healthcare sector, such as tissue engineering, self-assembling human-scale biomaterials, and organ printing. However, the mainstream use of 4D printing, along with its translatability, is dependent on further intensive research and advancements.Lay SummaryThe goal of 4D printing is to synthesize smart shape-changing products using conventional 3D printing instruments. The fourth dimension in 4D printing is “time.” Post printing, the 3D-printed construct can be transformed into the shape of interest by exposure to specific stimuli. 4D printing is a rapidly growing technology and has been explored in different fields including biomedical engineering. This review documented a detailed discussion regarding the application of 4D printing technology in the area of biomedical engineering.Future WorkOne of the major obstacles in 4D printing technology is cellular survival in the presence of a stimulus. The stimulus should require to be well optimized in order to support cellular survival. Other problems are passive and unreliable actuation, deficiency in regulating intermediary states of deformation and restriction in the availability of material. In future work, more effective techniques or optimized methodologies for governing the application of stimuli are required to make the technique flawless in this particular field.
... Conjugation of drugs to biocompatible polymers responsive to the tumor microenvironment improves their therapeutical activities (1)(2)(3)(4). Cancer cells favor glycolysis rather than oxidative phosphorylation in order to supply the required ATP with a fastmetabolic pathway. This reaction results in hypoxia in and around the tumor, and pH value decreases to 6.5-7.2, ...
... Since doxorubicin is the most extensively investigated topoisomerase inhibitor and enormous drug delivery systems for this molecule have been developed, the focus of the present review is on other topoisomerase inhibitors [37,77,78]. ...
Article
Topoisomerase enzymes have shown unique roles in replication and transcription. These enzymes which were initially found in Escherichia coli have attracted considerable attention as target molecules for cancer therapy. Nowadays, there are several topoisomerase inhibitors in the market to treat or at least control the progression of cancer. However, significant toxicity, low solubility and poor pharmacokinetic properties have limited their wide application and these characteristics need to be improved. Nano-delivery systems have provided an opportunity to modify the intrinsic properties of molecules and also to transfer the toxic agent to the target tissues. These delivery systems leads to the re-introduction of existing molecules present in the market as novel therapeutic agents with different physicochemical and pharmacokinetic properties. This review focusses on a variety of nano-delivery vehicles used for the improvement of pharmacological properties of topoisomerase inhibitors and thus enabling their potential application as novel drugs in the market.
... The HA-pHis micelles exhibit the highest degree of cellular uptake at the lowest degree of substitution. The Doxloaded polysebacic anhydride nano-carriers coated with pHis were also studied for the pHresponsive nano-carriers [76]. Interestingly nano-carriers covered with PEG reduced the macrophage uptake. ...
... The HA-pHis micelles exhibit the highest degree of cellular uptake at the lowest degree of substitution. The Dox-loaded polysebacic anhydride nano-carriers coated with pHis were also studied for the pH-responsive nano-carriers [76]. Interestingly nano-carriers covered with PEG reduced the macrophage uptake. ...
Article
Full-text available
Smart nano-carriers have attained great significance in the biomedical field due to their versatile and interesting designs with different functionalities. The initial stages of the development of nanocarriers mainly focused on the guest loading efficiency, biocompatibility of the host and the circulation time. Later the requirements of less side effects with more efficacy arose by attributing targetability and stimuli-responsive characteristics to nano-carriers along with their bio- compatibility. Researchers are utilizing many stimuli-responsive polymers for the better release of the guest molecules at the targeted sites. Among these, pH-triggered release achieves increasing importance because of the pH variation in different organ and cancer cells of acidic pH. This specific feature is utilized to release the guest molecules more precisely in the targeted site by designing polymers having specific functionality with the pH dependent morphology change characteristics. In this review, we mainly concert on the pH-responsive polypeptides and some interesting nano-carrier designs for the effective theranostic applications. Also, emphasis is made on pharmaceutical application of the different nano-carriers with respect to the organ, tissue and cellular level pH environment.
... Carboxyl, pyridine, sulfonic, phosphate, and tertiary amine groups in polymers ionize with changes in pH which results in structural or property changes, such as solubility, degradability, configuration, chain conformation swelling, surface activity, and self-assembly (Reyes-Ortega, 2014). pH responsive polymer systems have been utilized in several biomedical applications, such as drug delivery (Bagherifam et al., 2015), gene delivery, and glucose sensors due to their unique properties. ...
Article
Full-text available
Three-dimensional (3D) and Four-dimensional (4D) printing emerged as the next generation of fabrication techniques, spanning across various research areas, such as engineering, chemistry, biology, computer science, and materials science. Three-dimensional printing enables the fabrication of complex forms with high precision, through a layer-by-layer addition of different materials. Use of intelligent materials which change shape or color, produce an electrical current, become bioactive, or perform an intended function in response to an external stimulus, paves the way for the production of dynamic 3D structures, which is now called 4D printing. 3D and 4D printing techniques have great potential in the production of scaffolds to be applied in tissue engineering, especially in constructing patient specific scaffolds. Furthermore, physical and chemical guidance cues can be printed with these methods to improve the extent and rate of targeted tissue regeneration. This review presents a comprehensive survey of 3D and 4D printing methods, and the advantage of their use in tissue regeneration over other scaffold production approaches.
... These systems can improve the drug action efficiency and selectivity, reduce side effects and decrease the dose used. This refers, for example, to cytostatics [21][22][23][24][25][26], to other drugs and substances, including those that work synergistically and are co-transported together [27][28][29][30][31][32][33]. It should be noted in general that the number of reviews and original publications that consider certain aspects of formation and use of the nanostructured targeted delivery systems is large globally and is constantly growing. ...
... Besides, nanocapsules are able to reach an effective concentration in a quite short time period within 15-20 h. In vitro analyses on MDA-MB-231 breast cancer cell line showed the greatest antitumor activity of nanocapsules containing the highest concentration of DOX, as well as the greater amount of drug released from the non-PEGylated particles in macrophages than from PEGylated nanocapsules [183]. ...
Article
Full-text available
Nanotechnology, focused on discovery and development of new pharmaceutical products is known as nanopharmacology, and one research area this branch is engaged in are nanopharmaceuticals. The importance of being nano has been particularly emphasized in scientific areas dealing with nanomedicine and nanopharmaceuticals. Nanopharmaceuticals, their routes of administration, obstacles and solutions concerning their improved application and enhanced efficacy have been briefly yet comprehensively described. Cancer is one of the leading causes of death worldwide and evergrowing number of scientific research on the topic only confirms that the needs have not been completed yet and that there is a wide platform for improvement. This is undoubtedly true for nanoformulations of an anticancer drug doxorubicin, where various nanocarrriers were given an important role to reduce the drug toxicity, while the efficacy of the drug was supposed to be retained or preferably enhanced. Therefore, we present an interdisciplinary comprehensive overview of interdisciplinary nature on nanopharmaceuticals based on doxorubicin and its nanoformulations with valuable information concerning trends, obstacles and prospective of nanopharmaceuticals development, mode of activity of sole drug doxorubicin and its nanoformulations based on different nanocarriers, their brief descriptions of biological activity through assessing in vitro and in vivo behavior.
... To investigate the potential pH sensitivity of these PECs, a (HE) 20 copolymer composed of repeats of histidine and poly(glutamic acid) was used in place of E n for complex formation. Histidine has previously shown potential as a tool for pH-sensitive drug delivery [42][43][44][45][46][47] and the (HE) 20 copolymer specifically has been shown to enable pH-dependent internalization of cell penetrating peptides [21,23], thus making it a promising candidate for formation of pH-sensitive PECs. The (HE) 20 copolymer was mixed with K 55 at 1:1 molar charge ratios and, in the presence of zinc, was able to encapsulate the anticancer drug daunomycin. ...
Article
Full-text available
Polyelectrolyte complexes (PECs) are self-assembling nano-sized constructs that offer several advantages over traditional nanoparticle carriers including controllable size, biodegradability, biocompatibility, and lack of toxicity, making them particularly appealing as tools for drug delivery. Here, we discuss potential application of PECs for drug delivery to the slightly acidic tumor microenvironment, a pH in the range of 6.5–7.0. Poly(l-glutamic acid) (En), poly(l-lysine) (Kn), and a copolymer composed of histidine-glutamic acid repeats ((HE)n) were studied for their ability to form PECs, which were analyzed for size, polydispersity, and pH sensitivity. PECs showed concentration dependent size variation at residue lengths of E51/K55 and E135/K127, however, no complexes were observed when E22 or K21 were used, even in combination with the longer chains. (HE)20/K55 PECs could encapsulate daunomycin, were stable from pH 7.4–6.5, and dissociated completely between pH 6.5–6.0. Conversely, the E51-dauno/K55 PEC dissociated between pH 4.0 and 3.0. These values for pH-dependent particle dissociation are consistent with the pKa’s of the ionizable groups in each formulation and indicate that the specific pH-sensitivity of (HE)20-dauno/K55 PECs is mediated by incorporation of histidine. This response within a pH range that is physiologically relevant to the acidic tumors suggests a potential application of these PECs in pH-dependent drug delivery.